0001615774-16-008920.txt : 20161215
0001615774-16-008920.hdr.sgml : 20161215
20161214175431
ACCESSION NUMBER: 0001615774-16-008920
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20161215
DATE AS OF CHANGE: 20161214
EFFECTIVENESS DATE: 20161215
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Enumeral Biomedical Holdings, Inc.
CENTRAL INDEX KEY: 0001561551
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 990376434
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-276313
FILM NUMBER: 162051938
BUSINESS ADDRESS:
STREET 1: 200 CAMBRIDGEPARK DRIVE, SUITE 2000
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: (617) 674-1865
MAIL ADDRESS:
STREET 1: 200 CAMBRIDGEPARK DRIVE, SUITE 2000
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: CERULEAN GROUP, INC.
DATE OF NAME CHANGE: 20121102
D
1
primary_doc.xml
X0707
D
LIVE
0001561551
Enumeral Biomedical Holdings, Inc.
200 CAMBRIDGEPARK DRIVE, SUITE 2000
CAMBRIDGE
MA
MASSACHUSETTS
02140
617-945-9146
DELAWARE
Cerulean Group, Inc.
CERULEAN GROUP, INC.
Corporation
true
2012
Wael
Fayad
200 CambridgePark Drive, Suite 2000
Cambridge
MA
MASSACHUSETTS
02140
Executive Officer
Director
Kevin
G.
Sarney
200 CambridgePark Drive, Suite 2000
Cambridge
MA
MASSACHUSETTS
02140
Executive Officer
Barry
Buckland, Ph.D.
200 CambridgePark Drive, Suite 2000
Cambridge
MA
MASSACHUSETTS
02140
Director
Robert
J.
Easton
200 CambridgePark Drive, Suite 2000
Cambridge
MA
MASSACHUSETTS
02140
Director
Allan
P.
Rothstein
200 CambridgePark Drive, Suite 2000
Cambridge
MA
MASSACHUSETTS
02140
Director
Paul
J.
Sekhri
200 CambridgePark Drive, Suite 2000
Cambridge
MA
MASSACHUSETTS
02140
Director
Robert
L.
Van Nostrand
200 CambridgePark Drive, Suite 2000
Cambridge
MA
MASSACHUSETTS
02140
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2016-12-09
false
true
true
false
0
Katalyst Securities LLC
112494
None
None
15 MAIDEN LANE, ROOM 601
NEW YORK
NY
NEW YORK
10038
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
DE
DELAWARE
FL
FLORIDA
GA
GEORGIA
IL
ILLINOIS
IN
INDIANA
IA
IOWA
KY
KENTUCKY
MD
MARYLAND
MA
MASSACHUSETTS
MI
MICHIGAN
MN
MINNESOTA
MO
MISSOURI
NE
NEBRASKA
NV
NEVADA
NH
NEW HAMPSHIRE
NJ
NEW JERSEY
NY
NEW YORK
NC
NORTH CAROLINA
TX
TEXAS
WI
WISCONSIN
false
10774755
3431500
7343255
Pursuant to the issuer warrant tender offer, an aggregate of 6,863,000 Original Warrants were tendered and exercised.
false
108
255000
0
Cash compensation equal to 8% of the cash exercise prices paid by holders in the issuer warrant tender offer.
0
true
Enumeral Biomedical Holdings, Inc.
/s/ Kevin G. Sarney
Kevin G. Sarney
Vice President of Finance
2016-12-14